title: Reply to F.-C. Bidard et al.
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
authors: Jeffrey B
authors: JB
authors: Smerage
authors: SWOG Statistical Center, Seattle, WA.
authors: William E
authors: WE
authors: Barlow
authors: University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Gabriel N
authors: GN
authors: Hortobagyi
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI hayesdf@umich.edu.
authors: Daniel F
authors: DF
authors: Hayes
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D057915:Drug Substitution; D005260:Female; D006801:Humans; D009360:Neoplastic Cells, Circulating / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents